about
Simultaneous quantification of reparixin and paclitaxel in plasma and urine using ultra performance liquid chromatography-tandem mass spectroscopy (UHPLC-MS/MS): Application to a preclinical pharmacokinetic study in rats.Pre-Clinical Pharmacokinetic and Pharmacodynamic Characterization of Selected Chiral Flavonoids: Pinocembrin and Pinostrobin.Calebin A: Analytical Development for Pharmacokinetics Study, Elucidation of Pharmacological Activities and Content Analysis of Natural Health Products.Stereospecific pharmacokinetic characterization of liquiritigenin in the rat.Pharmacological characterization of liquiritigenin, a chiral flavonoid in licorice.Pharmacokinetic and Toxicodynamic Characterization of a Novel Doxorubicin Derivative.Mechanistically elucidating the in vitro safety and efficacy of a novel doxorubicin derivative.Disposition, Metabolism and Histone Deacetylase and Acetyltransferase Inhibition Activity of Tetrahydrocurcumin and Other Curcuminoids.Inhibition of BMP4 and Alpha Smooth Muscle Actin Expression in LX-2 Hepatic Stellate Cells by BMP4-siRNA Lipid Based Nanoparticle.Pharmaceutical Characterization of MyoNovin, a Novel Skeletal Muscle Regenerator: in silico, in vitro and in vivo Studies.DOX-Vit D, a Novel Doxorubicin Delivery Approach, Inhibits Human Osteosarcoma Cell Proliferation by Inducing Apoptosis While Inhibiting Akt and mTOR Signaling PathwaysChemical reactivity and microbicidal action of bethoxazinValidation of Cadherin HAV6 Peptide in the Transient Modulation of the Blood-Brain Barrier for the Treatment of Brain TumorsCorrection to: Mechanistically elucidating the in vitro safety and efficacy of a novel doxorubicin derivative
P50
Q33469791-D302C9B7-952F-48AF-844A-1B9A930C332BQ38655305-577FCA57-5CD0-4A17-80B0-E7596DB7D363Q38655322-D4DDA514-41FE-4738-A08B-4216F082F5AEQ38720114-91736455-0FED-4119-A584-9BE2D4FA61AAQ38727493-A1FFFA1C-2654-428A-A405-817BB0985145Q42366841-6F1034B1-DE11-4BE7-B8A3-60D8B6889D81Q46373476-00049D7E-6FCB-430E-8BF4-77621183431BQ48204217-2E46674B-1F70-47DD-A332-B56FA1CD7838Q51734773-0071ECC3-5C85-4C64-9D3D-45608984BD59Q53828493-033A17CB-8024-41BB-9EB2-37C6C696DC95Q58764297-5DEC4AC9-4452-4B7B-AC12-C59729F3F148Q83294996-A9FCFB16-E20C-4016-B897-5CF67F90BC26Q90164029-A8140C19-54AE-4C3E-9EF1-B94CCFB54EF8Q90729974-EDEDE16C-384B-422B-9084-3FA03595ABB4
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Samaa Alrushaid
@ast
Samaa Alrushaid
@en
Samaa Alrushaid
@es
Samaa Alrushaid
@nl
Samaa Alrushaid
@sl
type
label
Samaa Alrushaid
@ast
Samaa Alrushaid
@en
Samaa Alrushaid
@es
Samaa Alrushaid
@nl
Samaa Alrushaid
@sl
prefLabel
Samaa Alrushaid
@ast
Samaa Alrushaid
@en
Samaa Alrushaid
@es
Samaa Alrushaid
@nl
Samaa Alrushaid
@sl
P106
P31
P496
0000-0001-7705-9025